Histoplasmosis in African children: clinical features, diagnosis and treatment

Bassey Ewa Ekeng1, Kevin Edem2, Patricia Akintan3

  • 1Department of Medical Microbiology and Parasitology, University of Calabar Teaching Hospital, Calabar 540271, Nigeria.

Insights

This review highlights histoplasmosis in African children, finding disseminated disease common, often affecting skin and bones. It emphasizes the need for increased awareness and diagnosis beyond common pediatric conditions in Africa.

Area of Science:

  • Medical Mycology
  • Pediatric Infectious Diseases
  • Tropical Medicine

Background:

  • Histoplasmosis reviews predominantly focus on adult populations, with limited data on pediatric cases in Africa.
  • Histoplasmosis in African children presents unique clinical challenges and diagnostic considerations.

Purpose of the Study:

  • To review and summarize case reports of histoplasmosis in African children from 1950-2021.
  • To highlight clinical features, diagnostic methods, and outcomes of pediatric histoplasmosis in Africa.
  • To underscore the importance of considering histoplasmosis in the differential diagnosis of pediatric illnesses in Africa.

Main Methods:

  • Systematic review of 44 published case reports of histoplasmosis in African children.
  • Analysis of epidemiological data, causative species (Histoplasma capsulatum var. duboisii predominantly), clinical presentations, diagnostic modalities, and treatment outcomes.
  • Review of geographical distribution across African regions.

Main Results:

  • Central and Western Africa reported the highest number of cases. Histoplasma capsulatum var. duboisii was the most common etiological agent.
  • Disseminated histoplasmosis (56.8%) was prevalent, with frequent involvement of skin (65.9%), bones (45.5%), and lymph nodes (34.1%).
  • Histopathology was the primary diagnostic tool (75%). Amphotericin B and ketoconazole were common treatments, with a 61.4% favorable outcome rate. Misdiagnosis as tuberculosis, cancer, and other conditions was noted.

Conclusions:

  • Histoplasmosis in African children often presents as disseminated disease with extrapulmonary manifestations, particularly affecting the skin and bones.
  • There is a critical need for enhanced diagnostic awareness and capacity for histoplasmosis in African pediatric healthcare settings.
  • Pediatricians in Africa should broaden their differential diagnoses to include histoplasmosis, especially when common pediatric diseases are suspected but do not respond to treatment.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
158
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.2K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
261
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
375
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
498